NLS Pharmaceutics
NLSP
NLSP
9 hedge funds and large institutions have $1.85M invested in NLS Pharmaceutics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$51.2K |
| 2 |
AC
2
Armistice Capital
New York
|
$501K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$29.6K |
| 4 |
4
Jane Street
New York
|
$9.47K |
| 5 |
HF
5
HRT Financial
New York
|
$3K |
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$4.72K |
| 2 |
XT
2
XTX Topco
George Town,
Cayman Islands
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BI
1
BVF Inc
San Francisco,
California
| $1.25M | – | – | – |
|
|
AC
2
Armistice Capital
New York
| $501K | +$30.1K | +3,475 | +6% |
|
|
3
UBS Group
Zurich,
Switzerland
| $51.2K | +$51.2K | +5,893 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| $29.6K | +$25.4K | +2,927 | +610% |
|
|
5
Jane Street
New York
| $9.47K | +$9.47K | +1,092 | New |
|
|
6
Renaissance Technologies
New York
| $4.72K | -$34.3K | -3,945 | -88% |
|
7
Geode Capital Management
Boston,
Massachusetts
| $3.12K | – | – | – |
|
|
HF
8
HRT Financial
New York
| $3K | +$3K | +421 | New |
|
9
Bank of America
Charlotte,
North Carolina
| $19 | – | – | – |
|
|
XT
10
XTX Topco
George Town,
Cayman Islands
| – | -$4.65K | -640 | Closed |
|